Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Clinical hold placed on South African study of Coviracil

April 12, 2000

Sultams prove to be potent NNRTIs in biological screens; work presented at ACS meeting

April 10, 2000

Progenics reports HIV therapy progress at Keystone symposium

April 10, 2000

Potent second-generation HIV protease inhibitors designed by Vertex & Glaxo Wellcome

April 6, 2000

Immune Response to develop potential preventive HIV vaccine

April 3, 2000

Consensus receives SBIR grant to develop new class of HIV inhibitors

March 30, 2000

Leukocytosis following AMD-3100 is dose-related and reversible

March 23, 2000

Columbia Laboratories reacquires U.S. rights to Advantage-S

March 23, 2000

Progenics expands HIV program with Pharmacopeia, receives SBIR grant

March 21, 2000

Medivir reinitiates development of alovudine for AIDS

March 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...